Toray Develops Porous Fiber to Adsorb Pathogenic Substances in Intractable Diseases
NQ Score
45/100
AI Summary (NQ-processed)
Toray Industries has developed a technology to precisely control the pore size of PMMA porous fibers, enabling the selective adsorption of large-molecule pathogenic substances. This innovation offers a new blood purification treatment option for autoimmune, cardiovascular, neurodegenerative diseases, and cancer.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What diseases does this technology treat?
- A: It targets intractable diseases such as autoimmune disorders, cardiovascular diseases, neurodegenerative conditions, and cancer.